These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16280247)

  • 1. Selective serotonin re-uptake inhibition attenuates evoked glutamate release in the dorsal horn of the anaesthetised rat in vivo.
    Langman NJ; Smith CG; Whitehead KJ
    Pharmacol Res; 2006 Feb; 53(2):149-55. PubMed ID: 16280247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
    Romero L; Artigas F
    J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex.
    Gołembiowska K; Dziubina A
    Pol J Pharmacol; 2000; 52(6):441-8. PubMed ID: 11334237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA transporter type 1 (GAT-1) uptake inhibition reduces stimulated aspartate and glutamate release in the dorsal spinal cord in vivo via different GABAergic mechanisms.
    Smith CG; Bowery NG; Whitehead KJ
    Neuropharmacology; 2007 Dec; 53(8):975-81. PubMed ID: 17981306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
    Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist.
    Dijk SN; Francis PT; Stratmann GC; Bowen DM
    Br J Pharmacol; 1995 Aug; 115(7):1169-74. PubMed ID: 7582540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 and selective 5-HT1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in conditioned fear stress in the rat.
    Muraki I; Inoue T; Koyama T
    Eur J Pharmacol; 2008 May; 586(1-3):171-8. PubMed ID: 18423441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI).
    Hjorth S; Auerbach SB
    Behav Brain Res; 1996; 73(1-2):281-3. PubMed ID: 8788519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors.
    Bosker FJ; Folgering JH; Gladkevich AV; Schmidt A; van der Hart MC; Sprouse J; den Boer JA; Westerink BH; Cremers TI
    J Neurochem; 2009 Mar; 108(5):1126-35. PubMed ID: 19166502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.
    Hjorth S; Auerbach SB
    Eur J Pharmacol; 1994 Aug; 260(2-3):251-5. PubMed ID: 7988652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine(1A) receptor-mediated feedback: a microdialysis study in the amygdala.
    Bosker FJ; Cremers TI; Jongsma ME; Westerink BH; Wikström HV; den Boer JA
    J Neurochem; 2001 Mar; 76(6):1645-53. PubMed ID: 11259482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.
    Guiard BP; Przybylski C; Guilloux JP; Seif I; Froger N; De Felipe C; Hunt SP; Lanfumey L; Gardier AM
    J Neurochem; 2004 Apr; 89(1):54-63. PubMed ID: 15030389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.
    Nagayasu K; Yatani Y; Kitaichi M; Kitagawa Y; Shirakawa H; Nakagawa T; Kaneko S
    Br J Pharmacol; 2010 Dec; 161(7):1527-41. PubMed ID: 20698856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.
    Invernizzi R; Velasco C; Bramante M; Longo A; Samanin R
    Neuropharmacology; 1997; 36(4-5):467-73. PubMed ID: 9225271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
    Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
    Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.